Site Search

... TIME 35 Patient and Provider Advocacy Groups Endorse Step Therapy Reform Legislation (A4815/S3051)   April 2021 Dear Policymaker, On behalf of the New Jersey Step Therapy Coalition, an expansive and diverse group of patient advocacy groups who share a common goal of increasing access to ... by their health care provider. This insurance practice undermines a doctor’s ability to appropriately treat patients with serious diseases and can greatly impede patient recovery. The practice has grown increasingly difficult, causing many New Jerseyans with chronic diseases to suffer ... and caregivers reported that step therapy policies delayed their care, increased their stress and frustration, contributed to worse outcomes and cost them more out of pocket. Doctors reported that these requirements made it harder for them to treat patients, delayed treatment and were time ...

... -- February 21, 2012 -- The Food and Drug Administration (FDA) today announced that it is taking major steps to address a critical shortage of cancer drugs that has left patients without lifesaving medications such as Doxil and Methotrexate. "The actions announced today will help to ... patients who urgently need them." The American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), have been closely monitoring the growing drug shortage crisis, which has made it difficult or impossible for some cancer patients to get the ... have been forced to pay exorbitant prices through the emerging "grey market," where drugs in short supply are sold legally at a reported cost of up to 650 percent of the original price. Those families include Sara Stuckey, a Society volunteer from Lincoln, IL, who was told by her ...

WASHINGTON, D.C. – December 10, 2014  – The American Cancer Society Cancer Action Network (ACS CAN) together with a dozen groups representing patients, doctors and researchers submitted a letter to the Food and Drug Administration today commending the agency for a proposal that aims to implement appropriate and efficient oversight of laboratory developed tests (LDTs). The groups support consistent evaluation of tests and tools that have the power to inform diagnosis and treatment decisions.  Currently tests sold as complete kits are required to undergo ...

Washington, D.C.—An executive order issued today allows for the expansion of association health plans and changes the rules governing the length and renewability of short-term catastrophic insurance plans. A statement from Chris Hansen, President of the American Cancer Society Cancer Action Network (ACS CAN) follows: “Today’s executive order jeopardizes the ability of millions of cancer patients, survivors and those at risk for the disease from ...